These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11013157)

  • 1. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
    Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotics and neuroleptic malignant syndrome.
    Kohen D; Bristow MF
    Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
    Gram LF
    Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine and neuroleptic malignant syndrome.
    Tofler I
    Psychosomatics; 2002; 43(6):505-6; author reply 506. PubMed ID: 12444237
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible neuroleptic malignant syndrome associated with olanzapine.
    Nyfort-Hansen K; Alderman CP
    Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome associated with olanzapine therapy.
    Apple JE; Van Hauer G
    Psychosomatics; 1999; 40(3):267-8. PubMed ID: 10341541
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and low-dose olanzapine.
    Suh H; Bronson B; Martin R
    Am J Psychiatry; 2003 Apr; 160(4):796. PubMed ID: 12668376
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropletic malignant syndrome and olanzapine.
    Sierra-Biddle D; Herran A; Diez-Aja S; Gonzalez-Mata JM; Vidal E; Diez-Manrique F; Vazquez-Barquero JL
    J Clin Psychopharmacol; 2000 Dec; 20(6):704-5. PubMed ID: 11106147
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome associated with olanzapine].
    García López MM; Ciprés L; de Cendra E; Vilalta Franch J
    Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
    Mujica R; Weiden P
    Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical neuroleptic malignant syndrome?
    Haggarty JM; Husni M; Peat C; Allain S
    Can J Psychiatry; 1999 Sep; 44(7):711-2. PubMed ID: 10500880
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
    Malyuk R; Gibson B; Procyshyn RM; Kang N
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine usage associated with neuroleptic malignant syndrome.
    Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C
    Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrence of neuroleptic malignant syndrome with olanzapine treatment.
    Gheorghiu S; Knobler HY; Drumer D
    Am J Psychiatry; 1999 Nov; 156(11):1836. PubMed ID: 10553758
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine-induced neuroleptic malignant syndrome with mental retardation.
    Margolese HC; Chouinard G
    Am J Psychiatry; 1999 Jul; 156(7):1115-6. PubMed ID: 10401467
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine and NMS.
    Hickey C; Stewart C; Lippmann S
    Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
    [No Abstract]   [Full Text] [Related]  

  • 19. Finding drug link to reaction.
    Hammond C
    Am J Health Syst Pharm; 1999 Aug; 56(15):1558-9. PubMed ID: 10478998
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical neuroleptic malignant syndrome associated with olanzapine.
    Reeves RR; Torres RA; Liberto V; Hart RH
    Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.